Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Oct 23, 2009

Eurogentec Gains License from Applied Biosystems to Produce Oligonucleotide Probes

  • Eurogentec obtained a license from Applied Biosystems to manufacture and sell dual-labeled oligonucleotide probes worldwide for use in the 5´ Nuclease process. This process is one of the key technologies driving real-time PCR assays. 

    Eurogentec will be able to custom manufacture, market, and sell dual-labeled probes alone as well as in complete kits. These kits may contain dual-labeled probes, primers, and reagents packaged and sold with other components. The agreement grants limited pass-through use rights to Eurogentec’s research customers. The agreement also conveys rights to offer oligonucleotide design services for probes and primers for use in real-time PCR.



Related content

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »